The efficacy and safety of intravitreal dexamethasone implants for macular oedema secondary to retinal vein occlusion: 3-year experience

Acta Ophthalmologica

Volumn 94, Issue 7, 2016, Pages e674-e675

  Higham, Aisling ^a   Jacob, Sarita ^a   Cox, Miriam ^a   Baker, Catherine ^a   Al Husainy, Sahar ^a   Sivaraj, Ramesh ^a   Gibson, Jonathan M ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; RANIBIZUMAB; TRIAMCINOLONE; VASCULOTROPIN INHIBITOR; ANGIOGENESIS INHIBITOR; DRUG IMPLANT; GLUCOCORTICOID; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

BRANCH RETINAL VEIN OCCLUSION; CATARACT EXTRACTION; CENTRAL RETINA VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOPHTHALMITIS; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; INTRAVITREAL IMPLANT; LETTER; LOW LEVEL LASER THERAPY; MACULAR EDEMA; MAJOR CLINICAL STUDY; MONOTHERAPY; PATIENT PREFERENCE; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS HEMORRHAGE; ANTAGONISTS AND INHIBITORS; COMPLICATION; DRUG IMPLANT; INTRAVITREAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINAL VEIN OCCLUSION;

ANGIOGENESIS INHIBITORS; DEXAMETHASONE; DRUG IMPLANTS; DRUG SUBSTITUTION; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; RANIBIZUMAB; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84961780326     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.13021     Document Type: Letter

References (3)

1. Haller JA, Bandello F, Belfort R Jr et al. (2010): Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117: 1134–1146.e3.
2. Haller JA, Bandello F, Belfort R Jr et al. (2011): Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 118: 2453–2460.
3. NICE (2011): Dexamethasone Intravitreal Implant for the Treatment of Macular Oedema Secondary to Retinal Vein Occlusion, NICE technology appraisal guidance, 229 Edn, London: National Institute for Health and Clinical Excellence (NICE).